Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
astra zeneca
1 Injection
Durvalumab
Keep in cold place
Delivering To:
Overview
Imfinzi 120mg Injection is an anticancer drug used in the treatment of biliary tract cancers (cancer of the bile ducts), non-small cell lung cancer that has not spread outside your chest, small cell lung cancer (has spread within your lungs), liver cancer, and endometrial cancer. It blocks a protein known as PD-L1 on cancer cells. As a result, the immune system recognizes and attacks these cells more effectively. Imfinzi 120mg Injection is given as an intravenous infusion by a healthcare expert. |
Lung Cancer, Endometrial cancer, Liver Cancer, Duct Cancer, Gallbladder Cancer
Like other anticancer medicines, Imfinzi 120mg Injection also has some common to severe side effects. These are undesired symptoms observed in the body after taking this injection. Usually, they disappear with time as the body adjusts to the medicine. These adverse effects don't need special medical attention, but if you observe them continually, talk to your medical expert. Some of them are listed below: Rashes
Cough
Tiredness
Muscles pain
Flu-like symptoms
Fungal infection in the mouth
Chills and fever
Fast heart rate
Weight loss
Painful urination. Severe side effects:
Abnormal night sweating
Nasopharyngitis (inflammation in the throat and nose)
Upper respiratory tract infection
Severe lung infections (pneumonia)
Oedema peripheral (swelling of the legs)
Increased blood creatinine level
Pneumonitis (Lung inflammation)
An overactive thyroid gland can cause a fast heart rate or weight loss.
Dosage and duration of Imfinzi 120mg Injection are decided by the doctor based on the patient's health condition. It is advisable to take this medicine as prescribed by your medical practitioner and not skip your regular dosing schedule. It is necessary to inform your doctor if you have a history of cardiac disease or liver disease. Do not stop taking the medicine suddenly, unless your doctor tells you. This medicine is given under the strict supervision of a doctor. Do not self-administer. Overdose is a very unusual state for this medicine because it is given under the supervision of a healthcare provider. The doctor will provide emergency medical treatment. To make it more effective, take a balanced diet and take an adequate amount of vitamins and minerals while on treatment with Imfinzi 120mg Injection.
Imfinzi 120mg Injection works by blocking a protein called PD-L1, which is a monoclonal antibody. By inhibiting the PD-L1 protein, immune (T-cells) recognize and attack cancer cells because cancer cells use the PD-L1 protein to hide themselves from the immune system. Imfinzi 120mg Injection contains an active ingredient, Durvalumab, which is used to treat non-small lung cancer. This drug is also used in combination with cisplatin or carboplatin to treat small-cell lung cancer and in combination with gemcitabine to treat biliary tract cancer. This injection is not recommended for people under age 18.
Alcohol
consult your doctor
Avoid the consumption of alcohol while taking the Imfinzi 120mg Injection, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms.
Pregnancy
consult your doctor
Do not take the Imfinzi 120mg Injection without consulting the doctor in case of pregnancy.
Breast Feeding
consult your doctor
Imfinzi 120mg Injection is unsafe to use during breastfeeding as it may cause toxicity to the baby. It is safe if prescribed.
Driving
unsafe
Imfinzi 120mg Injection may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
safe if prescribed
Consumption of the Imfinzi 120mg Injection should be avoided without informing the doctor if you have any kidney-related issues.
Liver
safe if prescribed
Consumption of Imfinzi 120mg Injection should be avoided without informing the doctor if you have any liver-related issues.
It is advised not to miss any scheduled dosage of Imfinzi 120mg Injection. In case you miss a dose, consult your doctor immediately. Don't overdose to compensate for the missed one. Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Inform your healthcare professional if you are planning to be pregnant, as taking Imfinzi 120mg Injection can harm the unborn fetus.
Use reliable contraceptive or birth control methods to prevent pregnancy for 8 weeks before and after taking Imfinzi 120mg Injection.
It is advised not to breastfeed while going through treatment.
Wear sunscreen and sun barriers before moving outdoors, as Imfinzi 120mg Injection can increase the chances of skin damage from sunburn.
If you experience any gastrointestinal symptoms after taking Imfinzi 120mg Injection, such as diarrhea, abdominal pain, or nausea, inform your doctor immediately. He may prescribe you antiemetic medicines to reduce these side effects.
During pregnancy, it is not safe to take Docetero 80mg injection, as it can cause harm to the unborn baby. Also, during breastfeeding, this medicine must not be used. Please make sure to consult your healthcare provider regarding the same
Imfinzi 120mg Injection is a prescription-based anticancer medicine used to treat advanced-stage non-small cell lung cancer (NSCLC), biliary tract cancer, liver cancer, and endometrial cancer
This drug is not considered safe in patients who have autoimmune diseases, such as Rheumatoid Arthritis or multiple sclerosis. They can get severe side effects after taking Imfinzi 120mg injection.
Yes, Imfinzi 120mg Injection is used as a combination drug with immunotherapy drugs, such as tremelimumab, to boost immunity to stop the growth of cancer cells.
Imfinzi 120mg Injection is a prescription-based anticancer drug. This medicine should be given intravenously by an experienced nurse or doctor. Please do not self-administer.
Avoid exposure to the sun and infections, report if you observe any unusual symptoms, and share your medical history with your healthcare expert, especially if you have autoimmune conditions, are pregnant, planning to be pregnant, or are breastfeeding.
Some medical conditions may interact with Imfinzi 120mg Injection, such as if you are pregnant, breastfeeding, taking any prescribed medicine, or have a history of heart or kidney problems.
It is advised not to take alcohol while taking the Imfinzi 120mg Injection, because consuming alcohol can cause serious side effects and can damage your liver badly. Consult your doctor if you have concerns or queries.
As soon as you remember, take the missed dose. unless it's time for your next dose. You should never take a double dose to make up for a missed one.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
Kalemkerian GP, et al. (2024).Treatment Options for Relapsed Small-Cell Lung Cancer: What Progress Have We Made? Journal of Oncology Practice,14(6), 369-370.
Szumera-Ciećkiewicz A, et al. (2025). EGFR Mutation Testing on Cytological and Histological Samples in Non-Small Cell Lung Cancer: a Polish, Single Institution Study and Systematic Review of European Incidence. Int J Clin Exp Pathol. 2(6), 2800-12.
Keedy VL, et al. (2023). American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients with Advanced Non-Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy. J Clin Oncol. 29(3), 2121-27.
World Health Organization. (2024). International Agency for Research on Cancer. Available at http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.
Bridgewater JA, Goodman KA, Kalyan A, Mulcahy MF. (2023). Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling. Am Soc Clin Oncol Educ Book. 35(36), 194-203.
Flemming JA, Zhang-Salomons J, Nanji S, Booth CM. (2022). Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from a population-based study. Cancer. 122(16): 2534-2543.
Kenmotsu H, Saito Y, Ninomiya K, Uematsu S, Akdemir B, Fukui A, Koto R, Fujiwara M, Iwao C, Kitagawa H, Yoshino I, Gemma A, Mitsudomi T, Yamamoto N. (2023). Long-Term Safety and Effectiveness of Durvalumab in Unresectable Stage III NSCLC in Japan: A Multicenter Prospective Study (AYAME). J Thorac Oncol. 4(45), 1556-0864(25)01014-7.
Zukin M, Gondim V, Shimada AK, Lima EMEA, Mathias C, Barra WF, William Junior WN, Padoan M, Bittencourt Y, Yamamura R, Silva CEB, Rossato LJ, Monteiro CA, Jesus RG, Gössling G, Gelatti ACZ. (2024). Durvalumab as consolidation therapy in patients who received chemoradiotherapy for unresectable stage III NSCLC: Real-world data from an expanded access program in Brazil (LACOG 0120). J Bras Pneumol, 50(6), 20240228.
Fan H, Guan S, Ren K, Li X, Wang J, Bi N, Zhao L.(2023). Impact of duration of maintenance immunotherapy on the prognosis of locally advanced non-small cell lung cancer treated with chemoradiotherapy. Front Oncol. 5(13),1580396.
astra zeneca
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.